Cambridge in America — University of Cambridge Alumni in Life Sciences

Tuesday, July 23
6:00-7:30pmCost: This event is hosted by Dr. Oded Ben-Joseph (Darwin 1988), Managing Director, Outcome Capital, LLC, and is free to attend with prior RSVP.Outcome Capital, LLC
99 High Street, Suite 2900
Boston, MA

RSVP to Megan Cokely at megan@cantab.org

Cambridge in America’s Boston Regional Committee invites you to another exclusive event for Cambridge alumni working in the life sciences.

Join Professor Anna Philpott, the incoming head of the University’s School of Biological Sciences, for an update from the School and a first look at her vision for the future.

This will be a great opportunity for you to learn more about the work and research happening in the biological sciences at Cambridge while networking over drinks and light appetizers with fellow alumni in the life sciences.

To secure your place please RSVP to me at megan@cantab.org.

News December 03, 2025

A Panic Letter and the Quiet Reset of American Biotech

This article examines the quiet but profound reset underway in U.S. biotech, triggered by a rare combination of forces: delayed or reduced federal funding, large pharma cutting mid-stage partnerships, and venture capital pulling back as exits evaporate. Based on insights from Dr. Stanislav Glezer, it reveals a market splitting in two — with capital chasing late-stage and very early assets while Phase 1–2 companies are stranded in the middle. The piece also exposes how government uncertainty, shrinking NIH support, and overlooked patient-behavior realities are forcing founders to rethink their entire company lifecycle. In today’s environment, survival requires new strategies, new geographies, and a deeper understanding of human factors that no protocol can fix.

Outcome Capital Life Science Market Pulse, October 2025

Outcome Capital Life Science Market Pulse October 2025 Click to view our LifeSciences Pulse Newsletter

Download

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?